Research, Science and Treatments

Mesothelioma Conferences for 2016 Announced

We have recently announced the 2016 dates for our International Symposium on Malignant Mesothelioma. In an effort to make it easier for the mesothelioma-affected  community across the United States  to access life-saving information provided directly from top experts in mesothelioma, in 2016 the Symposium will consist of three individual conferences in three major cities: Houston, […]


Meso Foundation Participates in 2015 Weinman Symposium

Mary Hesdorffer, APRN, the executive director of the Mesothelioma Applied Research Foundation, was one of the 30 international speakers at the 2015 Weinman Symposium at the University of Hawaii Cancer Center.
The conference, which was sponsored by Weinman Foundation’s Honolulu chapter, the National Cancer Institute, National Institute of Environmental Health Sciences, International Association for the Study […]




BREAKING NEWS: Data Released from Anetumab Ravtansine Study

Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY 94-9343. Anetumab ravtansine is an antibody-drug conjugate directed against the target molecule mesothelin which is highly expressed on mesotheliomas.
“Anetumab ravtansine shows encouraging efficacy in patients with advanced mesothelioma which warrants […]